A detailed history of Banque Pictet & Cie Sa transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 48,045 shares of SRPT stock, worth $6.25 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
48,045
Previous 34,524 39.16%
Holding current value
$6.25 Million
Previous $5.45 Million 10.01%
% of portfolio
0.05%
Previous 0.05%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$124.33 - $156.75 $1.68 Million - $2.12 Million
13,521 Added 39.16%
48,045 $6 Million
Q2 2024

Jul 25, 2024

BUY
$113.33 - $163.85 $3.91 Million - $5.66 Million
34,524 New
34,524 $5.45 Million
Q2 2023

Aug 04, 2023

BUY
$106.4 - $157.19 $2.34 Million - $3.46 Million
22,028 Added 465.51%
26,760 $3.06 Million
Q1 2023

May 01, 2023

SELL
$117.53 - $155.99 $252,219 - $334,754
-2,146 Reduced 31.2%
4,732 $652,000
Q4 2022

Feb 06, 2023

SELL
$100.86 - $132.13 $3.67 Million - $4.81 Million
-36,372 Reduced 84.1%
6,878 $0
Q3 2022

Nov 10, 2022

BUY
$75.71 - $119.24 $2.01 Million - $3.17 Million
26,570 Added 159.29%
43,250 $4.78 Billion
Q2 2022

Aug 08, 2022

BUY
$62.69 - $88.44 $129,266 - $182,363
2,062 Added 14.11%
16,680 $1.25 Million
Q1 2022

May 04, 2022

BUY
$63.15 - $90.42 $923,126 - $1.32 Million
14,618 New
14,618 $1.14 Million

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $11.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.